Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06991816 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Brain&Senses Study

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 23, 2026 (before its estimated August 31, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Dec 31, 2025 to Aug 31, 2026
    • Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Study completion date: Jun 30, 2030 to Jun 30, 2031
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this longitudinal observational study is to evaluate the impact of sensory deficits (smell, hearing and balance on cognitive decline and quality of life in the medium term (5 years)) on a population of patients over 55. Patients will be evaluated by a neurologist, a neuropsychologist and an otolaryngologist who will perform olfactory, auditory and vestibular tests. The acquired data will then be analyzed with multivariate analysis to understand the effect of multisensory deficit on both cognition and quality of life with a particular focus on depression. The primary objective will be the evaluation of multiple deficits on cognition, the secondary will be aimed at understanding whether one sensory deficit more than another, e.g. smell versus hearing, will have a greater impact on the patient's conditions.
Trial Details
NCT Number NCT06991816
Lead Sponsor University of Campania Luigi Vanvitelli
Collaborators: Ospedali Riuniti Marche Nord, Fano-Pesaro Hospital
Conditions
(from sponsor)		 Mild Cognitive Impairment, Alzheimer Disease, Parkinson
Related terms Alzheimer Disease, Anosmia, Cognitive Dysfunction, Hearing Loss
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov